Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Feb 10, 2015
Insider Transaction Report
Form 4
Martin David
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2015-02-09$35.65/sh−2,000$71,300→ 377,189 total - Sale
Common Stock
2015-02-10$35.90/sh−3,500$125,650→ 372,689 total - Sale
Common Stock
2015-02-06$35.70/sh−1,000$35,700→ 379,189 total - Sale
Common Stock
2015-02-10$36.24/sh−1,000$36,240→ 376,189 total
Holdings
- 850(indirect: By Children)
Common Stock
- 350(indirect: By Children)
Common Stock
- 850(indirect: By Children)
Common Stock
- 20,800
Stock Option (right to buy)
Exercise: $8.83Exp: 2017-02-14→ Common Stock (20,800 underlying) - 234,395
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (234,395 underlying) - 90,580
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-06-11→ Common Stock (90,580 underlying) - 32,350
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (32,350 underlying)
Footnotes (3)
- [F1]Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.55 to $35.75 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Fully exercisable.